Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators

A practice guide to patient treatment

N. Goldschlager, A. Epstein, Paul Andrew Friedman, E. Gang, R. Krol, B. Olshanshy

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The potential for interaction between pacemakers and implantable cardioverter/defibrillators (ICDs) and the medical and nonmedical environment, and between these devices and certain cardioactive drugs, has been recognized for years. Whereas a number of experimental and clinical studies have been performed to define some of these interactions, in many instances data are sparse and anecdotal clinical experiences form the basis for decision making and recommendations. Nevertheless, given the proliferation of rhythm-management devices in use in the population today, practitioners may find a guide to management of these patients helpful. This management guideline is therefore offered not as an extensive, literature-based review, but as a framework on which to understand specific types of problems that may be encountered in the daily lives of patients who have such implanted devices.

Original languageEnglish (US)
Pages (from-to)649-655
Number of pages7
JournalArchives of Internal Medicine
Volume161
Issue number5
StatePublished - Mar 12 2001
Externally publishedYes

Fingerprint

Implantable Defibrillators
Equipment and Supplies
Pharmaceutical Preparations
Decision Making
Therapeutics
Guidelines
Population

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators : A practice guide to patient treatment. / Goldschlager, N.; Epstein, A.; Friedman, Paul Andrew; Gang, E.; Krol, R.; Olshanshy, B.

In: Archives of Internal Medicine, Vol. 161, No. 5, 12.03.2001, p. 649-655.

Research output: Contribution to journalArticle

@article{01b2de6dd2e64c598aac412b536ab144,
title = "Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: A practice guide to patient treatment",
abstract = "The potential for interaction between pacemakers and implantable cardioverter/defibrillators (ICDs) and the medical and nonmedical environment, and between these devices and certain cardioactive drugs, has been recognized for years. Whereas a number of experimental and clinical studies have been performed to define some of these interactions, in many instances data are sparse and anecdotal clinical experiences form the basis for decision making and recommendations. Nevertheless, given the proliferation of rhythm-management devices in use in the population today, practitioners may find a guide to management of these patients helpful. This management guideline is therefore offered not as an extensive, literature-based review, but as a framework on which to understand specific types of problems that may be encountered in the daily lives of patients who have such implanted devices.",
author = "N. Goldschlager and A. Epstein and Friedman, {Paul Andrew} and E. Gang and R. Krol and B. Olshanshy",
year = "2001",
month = "3",
day = "12",
language = "English (US)",
volume = "161",
pages = "649--655",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators

T2 - A practice guide to patient treatment

AU - Goldschlager, N.

AU - Epstein, A.

AU - Friedman, Paul Andrew

AU - Gang, E.

AU - Krol, R.

AU - Olshanshy, B.

PY - 2001/3/12

Y1 - 2001/3/12

N2 - The potential for interaction between pacemakers and implantable cardioverter/defibrillators (ICDs) and the medical and nonmedical environment, and between these devices and certain cardioactive drugs, has been recognized for years. Whereas a number of experimental and clinical studies have been performed to define some of these interactions, in many instances data are sparse and anecdotal clinical experiences form the basis for decision making and recommendations. Nevertheless, given the proliferation of rhythm-management devices in use in the population today, practitioners may find a guide to management of these patients helpful. This management guideline is therefore offered not as an extensive, literature-based review, but as a framework on which to understand specific types of problems that may be encountered in the daily lives of patients who have such implanted devices.

AB - The potential for interaction between pacemakers and implantable cardioverter/defibrillators (ICDs) and the medical and nonmedical environment, and between these devices and certain cardioactive drugs, has been recognized for years. Whereas a number of experimental and clinical studies have been performed to define some of these interactions, in many instances data are sparse and anecdotal clinical experiences form the basis for decision making and recommendations. Nevertheless, given the proliferation of rhythm-management devices in use in the population today, practitioners may find a guide to management of these patients helpful. This management guideline is therefore offered not as an extensive, literature-based review, but as a framework on which to understand specific types of problems that may be encountered in the daily lives of patients who have such implanted devices.

UR - http://www.scopus.com/inward/record.url?scp=0035848350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035848350&partnerID=8YFLogxK

M3 - Article

VL - 161

SP - 649

EP - 655

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 5

ER -